Pancreatic Cancer Research

Clinical trialObservationalCompleted

Registrar Performances in MIDP

Registrar Performance in Laparoscopic Distal Pancreatectomy and Its Effect on Postoperative Outcomes

Outcome
Finished, no results posted
Phase
Observational
Status
Completed
Study type
Observational
Start
1 December 2019
Ended
1 June 2020
Enrollment
71 participants
Sites
1
Primary outcomes
open conversion rate
Sponsor type
Academic / other
Results posted
No
Last update
12 June 2020

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

This study aimed to determine whether registrar involvement in minimally invasive distal pancreatectomy (MIDP) was associated with adverse outcomes.

Detailed description public domain (ClinicalTrials.gov)

From January 2009 to March 2020, data of all consecutive patients requiring distal pancreatectomy in our public tertiary hospital were prospectively collected and retrospectively analyzed. Registrars were progressively involved for MIDP since 2009 and their experience was: \< 5 open pancreatic resections, \< 5 MIDP and at least 30 advanced minimally invasive gastrointestinal resections. Outcome of patients who underwent either distal pancreatectomy by the consultant or registrars were compared. Our primary outcome was the conversion rate. The secondary outcomes were 90-days postoperative outcomes including CR-POPF defined and classified according to the 2016 ISGPF definition.